Acinetobacter baumannii is a rapidly evolving pathogen that largely inhabits intensive care
units (ICU). This opportunistic, gram-negative organism has shown noteworthy taxonomic …

Acinetobacter baumannii has been a major cause of nosocomial infections for decades. The
absence of an available vaccine coupled with emerging multidrug resistance has prevented …

Acinetobacter baumannii has recently crossed all lines once considered harmless, pushing
its way as a nosocomial pathogen. It had acquired resistance to almost all available …

Infections caused by multi-drug resistance Acinetobacter baumannii are increasing
worldwide. Discovery of the vaccine against this bacterium as a cost-effective and preventive …

Acinetobacter baumannii is a notorious Gram-negative healthcare-associated (nosocomial
and community-acquired) bacterial pathogen that causes a high mortality rate (up to 70%) …

Acinetobacter baumannii has emerged as one of major nosocomial pathogen and global
emergence of multidrug-resistant strains has become a challenge for developing effective …

Acinetobacter baumannii has become an important cause of human infections, most notably
in the hospital setting. In addition, the global dissemination of multidrug resistant strains has …

Acinetobacter baumannii (Ab) is a global emerging bacterium causing nosocomial infections
such as pneumonia, meningitis, bacteremia and soft tissue infections especially in intensive …

Multidrug-resistant Acinetobacter baumannii (A. baumannii) infections are becoming more
prevalent all over the world. As a cost-effective and preventative method, vaccination seems …

We are indeed fortunate that modern medicine continues to offer advancements that
promise better and longer lives. Delivering on that promise depends on our ability to …